Live Breaking News & Updates on Aziyo Biologics Company Profile
Stay updated with breaking news from Aziyo biologics company profile. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Aziyo Biologics (NASDAQ:AZYO – Get Free Report)‘s stock had its “overweight” rating reiterated by equities researchers at Cantor Fitzgerald in a research note issued to investors on Thursday, Benzinga reports. They presently have a $8.00 target price on the stock. Cantor Fitzgerald’s price objective indicates a potential upside of 436.91% from the company’s previous close. […] ....
Cantor Fitzgerald reissued their overweight rating on shares of Aziyo Biologics (NASDAQ:AZYO – Free Report) in a report released on Tuesday morning, Benzinga reports. They currently have a $8.00 target price on the stock. Cantor Fitzgerald also issued estimates for Aziyo Biologics’ FY2023 earnings at ($2.13) EPS and FY2024 earnings at ($1.43) EPS. Aziyo Biologics […] ....
Aziyo Biologics, Inc. (NASDAQ:AZYO – Get Free Report) was the target of a significant decline in short interest in the month of June. As of June 30th, there was short interest totalling 97,800 shares, a decline of 9.4% from the June 15th total of 108,000 shares. Based on an average daily trading volume, of 83,400 […] ....
Aziyo Biologics (NASDAQ:AZYO) Stock Price Up 6.8% theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.
Aziyo Biologics, Inc. (NASDAQ:AZYO – Get Rating) was the target of a large growth in short interest in April. As of April 30th, there was short interest totalling 160,800 shares, a growth of 97.8% from the April 15th total of 81,300 shares. Based on an average daily volume of 291,500 shares, the short-interest ratio is […] ....